Natasha Rekhtman

Dr. Natasha Rekhtman is a renowned molecular pathologist at MSK specializing in thoracic tumors. She has contributed to defining pathological standards for MET amplification assessment including IHC scoring criteria and FISH thresholds. Her research encompasses the molecular pathology of MET-driven NSCLC, including heterogeneous MET amplification patterns and their clinical significance. She is a leading voice in lung cancer molecular diagnostics.